Disciplined Investments, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Disciplined Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$700.03 - $830.35 $700 - $830	-1 Reduced 11.11%	8 $5,000
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $680 - $826	-1 Reduced 10.0%	9 $7,000
Q4 2022 Feb 01, 2023	BUY	$705.89 - $766.39 $705 - $766	1 Added 11.11%	10 $7,000
Q3 2022 Nov 03, 2022	BUY	$573.97 - $724.32 $1,721 - $2,172	3 Added 50.0%	9 $6,000
Q2 2022 Aug 09, 2022	SELL	$548.35 - $738.84 $1,096 - $1,477	-2 Reduced 25.0%	6 $4,000
Q1 2022 Apr 22, 2022	BUY	$595.12 - $698.43 $4,760 - $5,587	8 New	8 $6,000

1,500

83M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.